- 专利标题: Hepatitis C Inhibitor Compounds
-
申请号: US13278532申请日: 2011-10-21
-
公开(公告)号: US20120034187A1公开(公告)日: 2012-02-09
- 发明人: Montse LLINAS-BRUNET , Murray BAILEY , Punit BHARDWAJ , Josee BORDELEAU , Pasquale FORGIONE , Elise GHIRO , Vida GORYS , Nathalie GOUDREAU , Sylvie GOULET , Teddy HALMOS , Jean RANCOURT
- 申请人: Montse LLINAS-BRUNET , Murray BAILEY , Punit BHARDWAJ , Josee BORDELEAU , Pasquale FORGIONE , Elise GHIRO , Vida GORYS , Nathalie GOUDREAU , Sylvie GOULET , Teddy HALMOS , Jean RANCOURT
- 申请人地址: DE Ingelheim am Rhein
- 专利权人: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
- 当前专利权人: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
- 当前专利权人地址: DE Ingelheim am Rhein
- 主分类号: A61K38/21
- IPC分类号: A61K38/21 ; A61P31/12 ; A61K38/06 ; C07K5/08 ; A61K38/47 ; A61K38/48
摘要:
Compounds of formula (I): wherein B, X, R3, L0, L1, L2, R2, R1 and RC are defined herein. The compounds are useful as inhibitors of HCV NS3 protease for the treatment of hepatitis C viral infection.